FLT3 and acute myeloid leukemia: A second AML primagraft sample (#2) (disease stage at time of sample acquisition: relapsed after multiple modalities, Supplementary Table 2) was tested with midostaurin+/−PRT062607 at concentrations previously tested against FLT3-ITD-expressing cell lines (Figure 11D).